Mineralys Therapeutics, Inc. (MLYS)
(Delayed Data from NSDQ)
$12.93 USD
-0.59 (-4.36%)
Updated May 13, 2024 04:00 PM ET
After-Market: $12.92 -0.01 (-0.08%) 6:38 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.84 |
EPS Last Quarter | -0.70 |
Last EPS Surprise | -2.94% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.61 |
Next Year | -3.68 |
EPS (TTM) | -2.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.84 | -0.88 | -2.61 | -3.68 |
# of Estimates | 1 | 1 | 3 | 2 |
Most Recent Consensus | NA | NA | -2.04 | NA |
High Estimate | -0.84 | -0.88 | -2.04 | -3.67 |
Low Estimate | -0.84 | -0.88 | -3.38 | -3.69 |
Year ago EPS | -0.31 | -0.57 | -1.99 | -2.61 |
Year over Year Growth Est. | -170.97% | -54.39% | -31.16% | -41.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 1 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.84 | -0.88 | -2.61 | -3.68 |
7 Days Ago | -0.72 | -0.72 | -2.44 | -3.34 |
30 Days Ago | -0.72 | -0.72 | -2.44 | -3.34 |
60 Days Ago | -0.72 | -0.71 | -2.88 | -3.00 |
90 Days Ago | -0.72 | -0.71 | -2.88 | -3.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.84 | -0.88 | -2.90 | -3.68 |
Zacks Consensus Estimate | -0.84 | -0.88 | -2.61 | -3.68 |
Earnings ESP | 0.00% | 0.00% | -10.92% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.70 | -0.61 | -0.57 | -0.31 | NA |
Estimate | -0.68 | -0.85 | -0.72 | -0.83 | NA |
Difference | -0.02 | 0.24 | 0.15 | 0.52 | 0.22 |
Surprise | -2.94% | 28.24% | 20.83% | 62.65% | 27.20% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more